CRIS Q2 2020 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+12.7% YoY

Gross Profit

$2M94.8% margin

Operating Income

-$5M-230.1% margin

Net Income

-$7M-284.2% margin

EPS (Diluted)

$-3.39

QoQ Revenue Growth

-12.9%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$585,000

Balance Sheet

Total Assets

$45M

Total Liabilities

$75M

Stockholders' Equity

-$30M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+12.7%
Gross Profit	$2M	$2M	+11.6%
Operating Income	-$5M	-$6M	+11.6%
Net Income	-$7M	-$7M	+7.0%

Revenue Segments

Gross Royalty Revenue

$2M104%

Contra Revenue

-$86,000-4%